Saving Lives, Defeating Heart Disease - Eliminating Risk, Empowering Patients.

Our commitment to patient well-being has already made a difference, but there is an urgent need for new, innovative approaches to further reduce cardiovascular morbidity. We are devoted to protecting patient lives and providing long-term treatment for heart attack survivors to prevent secondary occurrences.

As we continue our efforts to extend the success of our therapies. Our ultimate goal is to eliminate cardiovascular risk and revolutionize secondary event prevention. Together, we envision a future where the global impact of heart disease is significantly diminished, and millions of lives are saved.

News & Highlights

Read all articles

  • Cardiovascular

    10 Thing You Should Know about 2025 ESC Dyslipidemia Guideline Update

    Read more

  • Cardiovascular

    Tips and Tricks for Dyslipidemia Management

    Read more

  • Cardiovascular

    From Risk to Results: Case-Based Lipid Management for PCPs

    Read more

  • 31 Aug – 2 Sep 2024

    AZ Spotlight | ESC 2024 Hybrid Congress

    Read more

4 march 2020

 Surrey UK

Shifting Perspectives of Antiplatelet Therapy: NSTE-ACS in the Setting of COVID 19 – by Datuk Dr Rosli Mohd Ali

Join the webcast and listen to cardiology expert Datuk Dr Rosli Mohd Ali sharing his topic “Shifting Perspectives of Antiplatelet Therapy: NSTE-ACS in the Setting of COVID 19”.

Play video